Capital Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57M Sell
14,072
-1,590
-10% -$371K 1.87% 14
2026
Q1
$3.83M Sell
15,662
-123
-0.8% -$28.6K 2.1% 13
2025
Q4
$3.27M Buy
+15,785
New +$3.12M 1.82% 13

Other funds holding JNJ

Capital Financial Group's JNJ Position: Q2 2026 in Review

Capital Financial Group reduced its Johnson & Johnson (JNJ) stake by 10% in Q2 2026, selling an estimated $371K and leaving 14,072 shares worth $3.57M. The position accounts for 1.87% of the portfolio, ranked #14.

Capital Financial Group first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.83M in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Capital Financial Group held 14,072 shares of Johnson & Johnson worth $3.57M as of Q2 2026.
  • Capital Financial Group sold 1,590 Johnson & Johnson shares in Q2 2026, an estimated $371K.
  • Johnson & Johnson made up 1.87% of Capital Financial Group's portfolio in Q2 2026, its #14 holding.
  • Capital Financial Group first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Capital Financial Group's Johnson & Johnson position peaked at $3.83M in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Capital Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.